Rare diseases
Investigational molecules
Locations
Back to France60 clinical trials in Clamart, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceFranceFranceFranceFranceFranceFranceFranceFranceFranceFranceFranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple myeloma treatment strategies, including studies evaluating novel combinations like elranatamab-lenalidomide and maintenance therapies. Several trials in Paris are exploring advanced treatments for non-small cell lung cancer, particularly in elderly patients.
Additional studies address breast cancer preservation and brain metastases treatment approaches.
Groundbreaking research in gene therapy for Crigler-Najjar syndrome and innovative treatments for glycogen storage disease type 1a. Studies focus on developing targeted therapeutic approaches for these rare conditions.
Emphasis on developing personalized treatment approaches for rare genetic conditions.
Studies examining corticosteroid insufficiency in critical illness and prevention of C. difficile infections in transplant patients. Research includes innovative approaches to acute osteomyelitis treatment in children.
Focus on improving patient outcomes in critical care settings and infection management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
